Proper Enterprise Value to Sales Ratio Helps Investors Determine Value of a Company | Financial Buzz

Proper Enterprise Value to Sales Ratio Helps Investors Determine Value of a Company

Enterprise value-to-sales ratio (EV/sales), compares the total value of a company to its annual sales, gives investors a quantitative metric of how much it costs to buy a company’s sales. The measure expands on the price-to-sales ratio (P/S), which uses market cap rather than enterprise value in its calculation. EV/sales ratio is recognized to be more accurate than the often-used P/S ratio as the latter fails to consider a company’s debt in its valuation. EV to-sales ratio values vary by industry. The lower the EV-to-sales ratio relative to the industry average, the more likely investors are to reap the benefits of an undervalued company.

Within the cannabis industry, data from 113 Canadian cannabis stocks indicated an average estimated EV/Sales ratio of 20.3x in 2019 and 5.9x in 2020. WeedMD, Inc. (TSX-V: WMD) (OTCQX: WDDMF) (FSE: 4WE), a producer and distributor of cannabis products for both medical and recreational markets, is expected to deliver substantially lower measures relative to the industry average. Based on the Company’s July 15 closing share price, WeedMD’s EV/Sales ratio is projected to be 4.3x in 2019 and 1.0x in 2020.

WeedMD’s quantitative measures and recent expansion moves puts the Company in a promising position for investors. Last month WeedMD said it finished up the outdoor planting of over 20,000 fully-rooted cannabis plants at its Strathroy, Ontario property. The Company is one of the first licensed producers in Canada to begin outdoor grow operations with its first harvest expected in October of this year. Just a day later, the Company announced it became the first licensed producer to be included in Canada’s Shoppers Drug Mart and TruTrace Technologies’ medical cannabis verification project. The pilot program uses TruTrace’s blockchain-based platform, StrainSecure, to confirm the origin and quality assurance of cannabis products.

WeedMD owns and operates two facilities: a 158-acre greenhouse and outdoor facility in Strathroy, Ontario and a 26,000 sq. ft. extraction and processing facility in Aylmer, Ontario. The Company has 136,000 square feet of licensed indoor and greenhouse production space and is expected to have a total footprint of more than 550,000 square feet of indoor and greenhouse production online in 2019.

Sponsored Content Release. Click for Full Disclosure

  • Sponsored Content Release, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For WeedMD Inc. financial and corporate news dissemination, has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: